10-Q: ModivCare Files for Chapter 11, Delisted from Nasdaq

ModivCare Inc. has filed for Chapter 11 bankruptcy reorganization and been delisted from Nasdaq, with its common stock now trading on the OTC Expert Market.

Summary

• ModivCare Inc. filed a voluntary petition for reorganization under Chapter 11 of the U.S. Bankruptcy Code on August 20, 2025, in the Southern District of Texas.
• The company's common stock was suspended from trading on The Nasdaq Global Select Market on August 28, 2025, and now trades on the Expert Market operated by the OTC Markets Group under the symbol MODVQ.
• The Plan of reorganization was confirmed by the Bankruptcy Court on December 15, 2025, aiming to restructure debt obligations and recapitalize the company.
• The restructuring plan contemplates reducing total funded debt by approximately $1.1 billion.
• Existing common stock will be canceled, released, discharged, and extinguished, with stockholders receiving no distribution as part of the restructuring.
• First lien lenders will convert approximately $871 million in principal claims into $200 million of exit debt and 98% of the reorganized debtors' pro forma equity.
• Second lien noteholders will convert approximately $316 million in principal claims into equity in the reorganized debtors' pro forma equity.
• Holders of Second Lien Notes Claims and other General Unsecured Claims will receive their pro rata share of 2% of the equity in the reorganized debtors' pro forma equity.
• The company secured up to $100 million in debtor-in-possession (DIP) financing to fund the Chapter 11 cases.
• ModivCare reported a net loss of $303.7 million for Q2 2025, significantly wider than the $128.9 million net loss for Q2 2024.
• For the six months ended June 30, 2025, the net loss was $354.1 million, compared to $151.2 million for the same period in 2024.
• Consolidated service revenue, net, decreased by 5.5% to $659.6 million in Q2 2025 from $698.3 million in Q2 2024.
• The company recorded a non-cash goodwill impairment charge of $263.4 million in Q2 2025, with $211.8 million in the PCS segment and $51.6 million in the Monitoring segment.
• Interest expense, net, increased by 86.0% to $37.1 million in Q2 2025, driven by new debt facilities and higher interest rates, including payment-in-kind (PIK) interest on Second Lien Notes.
• The company faces ongoing financial challenges, including increased transportation and caregiver costs not offset by reimbursement rate increases, contract losses, and membership declines.

Sentiment

Score: 1

Explanation: The company is in severe financial distress, evidenced by the Chapter 11 bankruptcy filing, Nasdaq delisting, significant net losses, and the complete elimination of value for existing common stockholders under the restructuring plan. While the restructuring aims for long-term viability, the immediate and direct impact on current investors is overwhelmingly negative.

Positives

• The pre-arranged Chapter 11 plan was confirmed by the Bankruptcy Court on December 15, 2025, providing a structured path for reorganization.
• The restructuring is expected to significantly deleverage the capital structure by reducing total funded debt by approximately $1.1 billion.
• Secured $100 million in debtor-in-possession (DIP) financing to ensure liquidity during the Chapter 11 proceedings.
• The NEMT segment's revenue per member per month increased by 20.1% in Q2 2025 and 18.0% in YTD 2025, partially offsetting membership declines.
• Cost optimization and digitization efforts in NEMT contact centers led to a decrease in payroll and related costs and other service expenses by $4.4 million (8.0%) in Q2 2025 and $13.3 million (11.5%) in YTD 2025.
• General and administrative expenses decreased across NEMT and PCS segments due to efforts to improve operational efficiency.

Negatives

• ModivCare Inc. filed for Chapter 11 bankruptcy reorganization on August 20, 2025, indicating severe financial distress.
• The company's common stock was delisted from Nasdaq on August 28, 2025, and now trades on the less liquid OTC Expert Market.
• Existing common stockholders will have their equity canceled and will receive no distribution under the confirmed Plan of reorganization.
• Reported a net loss of $303.7 million for Q2 2025, a substantial increase from $128.9 million in Q2 2024.
• Year-to-date net loss for June 30, 2025, was $354.1 million, compared to $151.2 million for the same period in 2024.
• Consolidated service revenue, net, decreased by $38.7 million (5.5%) in Q2 2025 and $72.5 million (5.2%) in YTD 2025.
• Incurred a significant non-cash goodwill impairment charge of $263.4 million in Q2 2025, primarily in the PCS and Monitoring segments.
• Interest expense, net, surged by 86.0% to $37.1 million in Q2 2025 due to new, higher-interest debt facilities and PIK interest.
• Experienced increased transportation and caregiver costs not offset by reimbursement rate increases, leading to lower profit margins.
• Suffered contract losses and membership declines, particularly in the NEMT segment due to Medicaid redetermination.
• Lengthened collection periods for accounts receivable due to complexities in payor arrangements negatively impacted cash flow and liquidity.
• Cash used in operating activities increased to $104.3 million for YTD 2025 from $45.7 million for YTD 2024.
• The company would have been unable to meet its minimum liquidity covenant of $25.0 million and Total Net Leverage Ratio and Interest Coverage Ratio covenants when the holiday expired on September 30, 2025, without additional liquidity or strategic transactions.

Risks

• The company is subject to significant risks and uncertainties associated with the Chapter 11 Cases, including potential failure to consummate the Plan as outlined in the RSA or delays in doing so.
• Termination of the RSA could materially and adversely affect the ability to consummate the Plan.
• Operating under Chapter 11 may restrict the company's ability to pursue business strategies and respond to events or opportunities in a timely manner.
• A long and protracted restructuring could materially adversely affect the business, financial condition, results of operations, and liquidity, potentially leading to liquidation.
• Historical financial information may be volatile and not indicative of future financial performance due to asset impairments, restructuring activities, and potential fresh start accounting.
• The Chapter 11 Cases consume a substantial portion of management's time and attention, potentially affecting business operations and increasing employee attrition.
• The composition of the Board of Directors may change upon emergence from bankruptcy, potentially altering future strategy and plans.
• Substantial doubt exists about the company's ability to meet its obligations and continue as a going concern.
• Cash flows may not provide sufficient liquidity during or after the Chapter 11 Cases, and exit financing may be insufficient to support operations.
• Transfers of equity and issuances of equity in connection with the Chapter 11 Cases may impair the ability to utilize federal income tax net operating loss carryforwards.
• The DIP Facility contains significant covenants and restrictions that could adversely affect the ability to operate the business and liquidity.
• Deriving a significant amount of revenue from a limited number of payors exposes the company to material adverse impacts if funding, financial viability, or relationships with these payors change.
• Contracts may not survive until the end of their stated terms, or may not be renewed or extended on satisfactory terms, particularly NEMT state Medicaid contracts (24.0% of NEMT revenue subject to 2025 renewal).
• Recent legislative changes introduced by the One Big Beautiful Bill Act (OBBBA) could adversely affect the business by imposing new restrictions on supplemental benefits, standardized eligibility criteria, and performance-based reimbursement in Medicare Advantage and Medicaid.
• Trading in the company's securities during the Chapter 11 Cases is highly speculative and poses substantial risks, with existing common stock expected to have no value.
• Trading on the Over-the-Counter (OTC) Expert Market is significantly more limited than Nasdaq, potentially resulting in a less liquid market and further depressing the trading price.

Future Outlook

The company expects to continue to generate negative cash flows from operations in the near term. Its ability to continue as a going concern is contingent upon successfully implementing a comprehensive restructuring, emerging from Chapter 11, and generating sufficient liquidity. The Plan contemplates reducing debt by approximately $1.1 billion and securing new financing, including up to $300 million in takeback term loans and a new $250 million revolving credit facility. However, there is no assurance that the restructuring will be completed on expected terms or at all, and existing common stockholders will be eliminated. The company may also need to raise additional funds post-emergence and faces risks from potential reluctance of payors or customers to do business with a company that recently emerged from Chapter 11. The company does not intend to list the new common stock on a national securities exchange or be subject to public reporting obligations post-reorganization.

Management Comments

• Management believes that the Restructuring of the Company through the Chapter 11 Cases will allow the Company to successfully emerge and continue to operate as a viable going concern.
• Management has concluded that substantial doubt exists about the Company's ability to continue as a going concern due to financial challenges, increased costs, contract losses, membership declines, and lengthened collection periods.
• Management can provide no assurance that the transactions described in the restructuring plan will be consummated.
• Management has evaluated events and transactions that occurred after the balance sheet date and through the date these unaudited condensed consolidated financial statements were filed with the SEC and considered the effect of such events in the preparation of these unaudited condensed consolidated financial statements.

Industry Context

The healthcare services industry, particularly non-emergency medical transportation, personal care, and in-home monitoring, is influenced by an aging population, increasing prevalence of chronic illnesses, and a shift towards value-based care. However, the industry also faces challenges from budget pressures on governments, Medicaid redetermination efforts leading to membership declines, and regulatory changes like the One Big Beautiful Bill Act (OBBBA). The OBBBA introduces new restrictions on supplemental benefits, standardized eligibility criteria, and performance-based reimbursement for Medicare Advantage and Medicaid plans, which could reduce plan flexibility, limit beneficiary access, and constrain reimbursement rates. Macroeconomic conditions, including high inflation, interest rates, and labor shortages, are increasing operating costs (e.g., transportation and caregiver wages) at a faster rate than reimbursement, impacting profit margins across the NEMT and PCS segments. The competitive landscape and complex regulatory environment further intensify these pressures.

Comparison to Industry Standards

• The filing does not provide specific comparisons to industry standards or comparable companies, projects, and results. The focus is on internal financial performance and the ongoing bankruptcy restructuring.

Management Changes

Corporate Governance

Legal Proceedings

• A class action complaint was filed on January 29, 2025, by Dinesh Kalera against the company and three officers, alleging federal securities law violations related to NEMT segment accounts receivable, cash flow, and contractual terms. The court appointed a lead plaintiff on October 27, 2025, who will file an amended complaint on January 9, 2026. The defendants dispute the allegations and intend to defend vigorously.
• A putative shareholder derivative complaint was filed on May 12, 2025, by Zane Whitfield against current and former directors and executive officers, alleging breaches of fiduciary duties related to false statements and stock repurchases at inflated prices. This case was voluntarily dismissed on September 10, 2025, and the court entered an order dismissing it on September 15, 2025.
• A class action lawsuit against All Metro Home Care Services of New York, Inc. (a PCS segment subsidiary) since 2017 claims improper payment to live-in caregivers. Discovery is ongoing, despite a 2019 New York Court of Appeals ruling supporting the company's payment method. All Metro believes it is in compliance and intends to defend itself vigorously.
• All legal proceedings have been automatically stayed as a result of the Chapter 11 Cases, with the stay to be lifted upon the effectiveness of the Plan.

Related Party Transactions

• Schematyx, Inc., an entity in which AI Catalyst Fund, L.P. (a greater than five percent stockholder) is an equity owner, provided strategic support relating to AI assessment on a pro bono basis, completing services in Q2 2025.
• Following the pro bono services, ModivCare Solutions, LLC entered into separate consulting agreements on May 1, 2025, with two individual equity owners of Schematyx (one of whom is a co-founder and general partner of AI Catalyst). These consultants provided strategic advisory and technical guidance for AI, automation, and modernization objectives, aiming for annual operational expense reduction. They were paid an aggregate of $100,000 per month plus expenses for up to three months, with services completed on August 9, 2025. These agreements were approved by the Audit Committee.

Stakeholder Impact

• **Shareholders:** Existing common stockholders will have their equity canceled and receive no distribution, resulting in a complete loss of investment.
• **Creditors (First Lien Lenders):** Will convert approximately $871 million in claims into $200 million of exit debt and 98% of the reorganized company's pro forma equity, indicating a significant recovery but also a conversion of debt to equity.
• **Creditors (Second Lien Noteholders & General Unsecured Claims):** Will convert approximately $316 million in claims into equity and receive a pro rata share of 2% of the reorganized company's pro forma equity, subject to dilution, and New Warrants. This represents a substantial haircut and conversion to equity.
• **Employees:** May experience increased attrition due to the Chapter 11 Cases, diversion of management attention, and uncertainty. Vesting of equity awards has been tolled and awards are expected to be canceled. The Employee Stock Purchase Plan has been suspended. Loss of key personnel is a risk.
• **Customers/Payors:** The pendency of Chapter 11 Cases could affect their willingness to continue utilizing services and maintaining contracts, potentially leading to further contract losses. Regulatory changes (OBBBA) may also impact service offerings and reimbursement rates.
• **Suppliers/Vendors:** Relationships may be strained due to the bankruptcy, and the company's ability to enter into or maintain critical contracts at competitive rates is at risk.
• **Management:** Significant time and effort are consumed by the Chapter 11 Cases, diverting focus from business operations. The composition of the Board of Directors may change post-bankruptcy.

Next Steps

• The lead plaintiff in the Dinesh Kalera class action lawsuit will file an amended complaint on January 9, 2026.
• The company will continue to operate as a debtor-in-possession under the jurisdiction of the Bankruptcy Court.
• The company aims to successfully emerge from the Chapter 11 Cases and implement the comprehensive restructuring plan.
• The company will evaluate whether to elect a PIK interest payment or a cash interest payment for future interest payments on Second Lien Notes, considering liquidity and strategic objectives.
• The company will monitor the performance of the business, stock price, estimated fair values of reporting units, and legislative impacts of the OBBBA to determine if additional impairments to goodwill or intangible assets are required.
• The reorganized company does not intend to list the new common stock on Nasdaq, NYSE, or any other national securities exchange, or be subject to public reporting obligations under the Exchange Act.

Key Dates

Recommendation

The company has filed for Chapter 11 bankruptcy, and the confirmed reorganization plan explicitly states that existing common stockholders will have their equity canceled and receive no distribution. This means current shares are expected to become worthless. The delisting from Nasdaq and trading on the OTC Expert Market further reduces liquidity and investor confidence. While the restructuring aims for long-term viability for the reorganized entity, it offers no recovery for current equity holders. Therefore, a seasoned investor would strongly recommend selling any remaining shares to avoid a complete loss, if any market for them still exists.

Keywords

Chapter 11, Bankruptcy, Restructuring, Delisting, OTC Markets, Healthcare Services, Non-Emergency Medical Transportation (NEMT), Personal Care Services (PCS), In-Home Monitoring, Goodwill Impairment, Debt Restructuring, DIP Financing, Equity Rights Offering, Medicaid Redetermination, OBBBA, Financial Distress, Corporate Governance, SEC Filing